Adenosine (P1) receptor signalling

Drug Development Research

Volumn 39, Issue 3-4, 1996, Pages 262-268

  Fredholm, Bertil B ^a   Arslan, Giulia ^a   Kull, Björn ^a   Kontny, Ewa ^a   Svenningsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

G protein; Gene transcription; Second messenger

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENYLATE CYCLASE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE C; PROTEIN KINASE C;

ASTROCYTOMA CELL; CONFERENCE PAPER; ENZYME ACTIVITY; ERYTHROLEUKEMIA CELL; HISTOCHEMISTRY; HUMAN; MOLECULAR CLONING; NONHUMAN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0030428130     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<262::AID-DDR5>3.0.CO;2-P     Document Type: Conference Paper

References (59)

1. 3 receptors in rat brain. Mol Pharmacol 48:1038-1045.
2. 2+-ionophore-induced secretion in a rat mast cell line. J Pharmacol Exp Ther 276:837-845.
3. Altiok N, Balmforth AJ, Fredholm BB (1992): Adenosine receptor induced cAMP changes in D384 astrocytoma cells and the effect of bradykhiin thereon. Acta Physiol Scand 144:55-63.
4. Altiok N, Fredholm BB (1992): Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells: Evidence against a role of cyclic GMP. Neurochem Int 21:209-213.
5. Altiok N, Fredholm BB (1993): Bradykinin inhibits cyclic AMP accumulation in D384-luunan astrocytoma cells via a calcium-dependent inhibition of adenylyl cyclase. Cell Signal 5:279-288.
6. 1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Nenrosci Lett 185:29-32.
7. 2-bradykinin receptor linked to phospholipase C and inhibition of dopamine stimulated cyclic AMP accumulation in the human astrocytoma cell line D384. Naunyn-Sehmiedeberg's Arch Pharmacol 346:303-310.
8. Birnbaumer L (1993): Heterotrimeric G proteins: Molecular diversity and functional correlates. J Recept Res 13:19-26.
9. 2, adenosine receptor in N1H 3T3 fibroblasts. Biochem Pharmacol 47:801-814.
10. Cronstein BN (1994): Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13.
11. 2a receptors in the rat hippocampus. Brain Res 649:208-216.
12. 2A receptors. Naunyn-Schmiedeberg's Arch Pharmacol 353:261-271.
13. 2b, receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythrolenkemia cells. Mol Pharmacol 45:1160-1167.
14. 2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 88:7238-7241.
15. 2 adenosine receptor: Selective co-expression with Do dopamine receptors in rat striaturn. Mol Brain Res 14:186-195.
16. Fredholm BB (1995): Modulation of neurotransmitter release by heteroreceptors. In Powis DA, Bunn SJ (eds): Neurotransmitter release and its modulation: Biochemical mechanisms, physiological function and clinical relevance. Cambridge: Cambridge University Press, pp 104-121.
17. Fredholm BB, Dunwiddie TV (1988): How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130-134.
18. Fredholm BB, Abbracchio MR Burnstock G, Duly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994): Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
19. 1 receptors. In Belardinelli L, Pelleg A (eds): Adenosine and adenine nucleotides: From molecular biology to integrative physiology. Norwell: Kluwer, pp 103-112.
20. 2 receptors mediate the inhibitory effect of adenosine on IMLP-stimulated respiratory burst in neutrophil leukocytes. Naunyn-Schmiedeberg's Arch Pharmacol 354:262-267.
21. 1-adenosine receptor with recombinant G protein alpha-subunits. Selectivity for rGi alpha-3. J Biol Chem 266: 17778-17783.
22. 1 and bradykinin receptors increases protein kinase C and phospholipase D activity in smooth muscle cells. Naunyn-Schmiedeberg s Arch Pharmacol 351:186-193.
23. Greene RW, Haas HL (1985): Adenosine actions on CA1 pyramidal neurones in rat hippocampal slices. J Physiol 366:119-127.
24. 3 receptor-mediated hypotension in the rat. Br J Pharmacol 115:945-952.
25. 1 receptor with adenylyl cyclase. J Neurosci 13:2237-2248.
26. 3-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 20:689-699.
27. 3H]CGS 21680. Eur J Pharmacol 168:243-246.
28. Jonzon B, Nilsson J, Fredholm BB (1985): Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J Cell Physiol 124:451-456.
29. 2a receptor is not mediated by increases in cyclic AMP. J Neurochem 64:2801-2809.
30. Kontny E, Kvanta A, Fredholm BB (1992): Activation of protein kinase C and elevation of cAMP interact synergistically to raise c-Fos, c-Jun and AP-1 activity in Jurkat cells. Eur J Pharmacol, Mol Pharmacol Sect 227:333-338.
31. Kvanta A, Fredholm BB (1994): Synergistic effects between protein kinase C and cAMP on activator protein-1 activity and differentiation of PG-12 pheochromocytoma cells. J Mol Nenrosci 4:205-214.
32. Kvanta A, Nordstedt C, Jondal M, Fredholm BB (1989): Activation of protein kinase C via the T-cell receptor complex potentiates cyclic AMP responses in T-cells. Naunyn-Schmiedeberg's Arch Pharmacol 340:715-717.
33. Kvanta A, Gerwins P, Jondal M, Fredholm BB (1990): Stimulation of T-cells with OKT3 antibodies increases forskolin binding and cyclic AMP accumulation. Cell Signal 2:461-470.
34. Kvanta A, Jondal M, Fredholm BB (1991a): CD3-dependent increase in cyclic AMP in human T-cells following stimulation of the CD2 receptor. Biochim Biophys Acta 1093:178-183.
35. Kvanta A, Jondal M, Fredholm BB (1991b): Translocation of the alpha-and beta-isofonns of protein kinase C following activation of human T-lymphocytes. FEES Lett 283:321-324.
36. Kvanta A, Kontny E, Jondal M, Okret S, Fredholm BB (1992): Mitogen stininhition of T-cells increases c-Fos and c-Jun protein levels, AP-1 binding and AP-1 transcriptional activity, Cell Signal 4:275-286.
37. Ledent G, Dumont JE, Vassart G, Parmentier M (1992): Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J 11:537-542.
38. 3 adenosine receptor with widespread tissue distribution. Mol Pharmacol 44:524-532.
39. 16 as a universal G protein adapter: implications for agonist screening strategies. Trends Pharmacol Sci 17:235-237.
40. o. J Biol Chem 266:22285-22289.
41. Nordstedt G, Kvanta A, van der Ploeg I, Fredholm BB (1989): Dual effects of protein kinase-C on receptor stimulated cAM P accumulation in a Immun T-cell leukemia line. Eur J Pharmacol, Mol Pharmacol Sect 172:51-60.
42. 2A receptors. Drug Dev Res 39:450-460.
43. Palmer TM, Stiles GM (1995): Adenosine receptors. Neuropharmacology 34:683-694.
44. 3H]-CGS 21680 as a ligand, Nannyn-Schmiedeberg's Arch Pharmacol 342:85-89.
45. 2b, receptors from human brain. Biochem Biophys Res Commun 187:86-93.
46. 2 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
47. 3 adenosine receptor. Proc Natl Acad Sci USA 90:10365-10369.
48. Shen MR, Linden J, Chen SS, Wu SN (1993): Identification of adenosine receptors in human spermatozoa. Clin Exp Pharmacol Physiol 20:527-534.
49. 2-adenosine receptor subtype. Mol Endocrinol 6:384-393.
50. Svenningsson P, Nomikos GG, Fredholm BB (1995): Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J Neurosci 15:7612-7624.
51. Trussell LO, Jackson MB (1985): Adenosine-activated potassium conductance in cultured striatal neurons. Proc Natl Acad Sci USA 82:4857-4861.
52. van der Ploeg I, Altiok N, Kvanta A, Nordstedt C, Fredholm BB (1991): Role of a pertussis toxin sensitive G-protein in mediating the effects of phorbol esters on receptor activated cyclic AMP accumulation in Jurkat cells. Naunyn-Schmiedeberg's Arch Pharmacol 344:611-617.
53. 2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol 353:250-260.
54. 2H]CGS 21680 to human platelet membranes. Biochem Pharmacol 48:1658-1661.
55. 2a adenosine receptor gene expression in developing rat brain. Brain Res Mol Brain Res 20:313-327.
56. Weaver DR, Reppert SM (1992): Adenosine receptor gene expression in rat kidney. Am J Physiol 263:F991-F995.
57. Wu YN, Mercuri NB, Johnson SW (1995): Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J Pharmacol Exp Ther 273:576-581.
58. 2b, receptor in Xenopus oocytes. Mol Pharmacol 43:277-280.
59. 3 adenosine' receptor. Proc Natl Acad Sci USA 89:7432-7436.